Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Coordinated post-myocardial infarction care versus the PCSK9 modulator drug program: a comparative outcomes study

Despite effective and innovative contemporary therapies, survivors of acute myocardial infarction (AMI) remain at high risk for recurrent events and death. In Poland, two distinct nationwide pathways address this risk: KOS-Zawał, a multidisciplinary programme combining early cardiac rehabilitation, lifestyle coun...

M. Banach, M. Kruk, B. Koń et al. · 0 citations
Review Open access Oct 2026

The additive prognostic value of C-reactive protein for all-cause and cardiovascular mortality across the PREVENT-defined cardiovascular risk continuum: a nationally representative cohort study

High-sensitivity C-reactive protein (hsCRP) is a recognized cardiovascular risk-enhancing factor, yet whether its prognostic value varies across the spectrum of baseline cardiovascular risk defined by the American Heart Association (AHA) PREVENT equations remains unknown. To evaluate the additive prognosti...

V. Jaiswal, A. Bouras, A. Jaiswal et al. · 0 citations
Open access Oct 2026

Lipoprotein(a) adds no predictive value for coronary disease beyond traditional risk factors

Elevated lipoprotein(a) [Lp(a)] is considered a causal cardiovascular risk factor, yet its independent contribution to coronary artery disease (CAD) in contemporary clinical practice remains uncertain. Determining whether Lp(a) adds predictive value beyond established risk factors is essential for risk stratifica...

B. Sosnowska, J. Lewek, A. Bielecka-Dabrowa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.